coffeesai Ltd.

Coffeesai Ltd. is a biotechnology company that develops sustainable cell-based coffee products. The company utilizes a proprietary 3D cell expansion technology, originally developed for regenerative medicine by its parent company, Pluri Inc., to cultivate coffee in laboratory environments. By isolating cells from coffee plant leaves and growing them in controlled bioreactors, Coffeesai produces a biomass that captures the aroma, flavor, and texture of coffee without requiring traditional farming, deforestation, or extensive land and water resources. The technology is designed for scalability, with the company claiming the ability to produce the coffee equivalent of 1,000 trees in approximately three weeks.

This approach aims to mitigate the environmental impact of the global coffee industry and address supply chain risks associated with climate change and land scarcity. Coffeesai is currently in the development phase, focusing on product optimization, regulatory processes, and commercial scaling. The company has entered into strategic collaborations, such as a partnership with the Instituto del Café de Chiapas (INCAFECH) in Mexico, to leverage regional agricultural expertise and infrastructure. Coffeesai intends to license its technology to international partners to enable global production, targeting a commercial rollout within the coming years.